Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113957461B reveals metal-free electrochemical route for 1,1'-binaphthyl. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110540516B reveals visible-light mediated synthesis of dihydronaphthalenes. High yield, mild conditions, reliable pharmaceutical intermediate supplier.
Novel base-promoted synthesis of 5-CF3-1,2,3-triazoles avoiding toxic azides. Offers cost-effective, scalable routes for pharmaceutical and agrochemical intermediates.
Patent CN111662290B details an efficient Cu-catalyzed synthesis of benzoindolizines using alkynones and quinoline N-oxides, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN117164492B details metal-free photocatalytic synthesis. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Novel copper-catalyzed cyanation method offers mild conditions and high yields for anti-inflammatory intermediates, ensuring reliable supply chain stability.
Patent CN119874555A reveals a room-temperature, catalyst-free synthesis for beta-chloroenamides. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Lewis acid-catalyzed rearrangement offers mild conditions and high purity for pharmaceutical intermediate manufacturing and supply chain stability.
Novel Cu/g-C3N4 catalyzed route offers high yields and recyclability for trifluoromethyl benzimidazole intermediates, ensuring cost-effective supply chain solutions.
Novel ZnBr2-catalyzed ring contraction method for high-purity pyrazoles. Reduces steps and cost in API manufacturing with scalable room temperature processes.
Patent CN109096162B details a mild Scandium(III) catalyzed synthesis of sulfur-containing intermediates, offering cost reduction in API manufacturing and scalable production.
Novel elemental sulfur-promoted synthesis reduces costs and enhances safety for high-purity pharmaceutical intermediates manufacturing supply chains.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112898192B reveals a safe, efficient palladium-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113636968B details a novel Ru-catalyzed route for 3-acylpyrroles. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN112812032A reveals a green route to acetamides using dimethyl carbonate, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN112047879B details a novel copper-catalyzed method for selective halogenation, offering cost-effective and scalable solutions for API intermediate manufacturing.
Patent CN108558635B reveals a transition-metal-free route for 3-arylpropynoic acids using atmospheric CO2, offering significant cost reduction and supply chain reliability.
Novel room temperature nitration process enhances purity and yield. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN112898192B reveals a safe, efficient palladium-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and reliable supply chain solutions.